Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Competing Risk Analyses of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma
Dongjun Dai et al.
SCIENTIFIC REPORTS (2020)
Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes
Amy C. Moreno et al.
JOURNAL OF CANCER (2020)
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes
Nancy Tray et al.
BREAST (2019)
Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
Zahraa Al-Hilli et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Metaplastic carcinoma of the breast: Prognosis and response to systemic treatment in metastatic disease
Sari Takala et al.
BREAST JOURNAL (2019)
Therapeutic landscape of metaplastic breast cancer
N. Tray et al.
CANCER TREATMENT REVIEWS (2019)
The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database
Yongfeng Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis
Xuexin He et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database
Cecilia T. Ong et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer
Reva K. Basho et al.
ONCOLOGIST (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Overview of model validation for survival regression model with competing risks using melanoma study data
Zhongheng Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1
Upasana Joneja et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature
Dima El Zein et al.
CLINICAL BREAST CANCER (2017)
Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study
E. A. Rakha et al.
BRITISH JOURNAL OF CANCER (2015)
Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center
Yiqian Zhang et al.
PLOS ONE (2015)
Towards better clinical prediction models: seven steps for development and an ABCD for validation
Ewout W. Steyerberg et al.
EUROPEAN HEART JOURNAL (2014)
The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments
Peter C. Austin
STATISTICS IN MEDICINE (2014)
Calibration plots for risk prediction models in the presence of competing risks
Thomas A. Gerds et al.
STATISTICS IN MEDICINE (2014)
Metaplastic Breast Carcinoma: Case Series and Review of the Literature
Onur Esbah et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Phase I Study of the Antiangiogenic Antibody Bevacizumab and the mTOR/Hypoxia-Inducible Factor Inhibitor Temsirolimus Combined with Liposomal Doxorubicin: Tolerance and Biological Activity
John Moroney et al.
CLINICAL CANCER RESEARCH (2012)
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
I. C. Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients
Soo Youn Bae et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Breast carcinoma-rare types: review of the literature
R. Yerushalmi et al.
ANNALS OF ONCOLOGY (2009)
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Bryan T. Hennessy et al.
CANCER RESEARCH (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
Therapeutic strategies for breast cancer based on histological type
Futoshi Akiyama et al.
BREAST CANCER (2009)
Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition
H. C. Lien et al.
ONCOGENE (2007)
Competing risk analysis using R: an easy guide for clinicians
L. Scrucca et al.
BONE MARROW TRANSPLANTATION (2007)
Share Paper
